Kristin Yarema
2023
In 2023, Kristin Yarema earned a total compensation of $2.4M as President, Cell Therapy at Poseida Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $171,280 |
|---|---|
| Option Awards | $934,210 |
| Salary | $380,625 |
| Stock Awards | $934,910 |
| Other | $13,540 |
| Total | $2,434,565 |
Yarema received $934.9K in stock awards, accounting for 38% of the total pay in 2023.
Yarema also received $171.3K in non-equity incentive plan, $934.2K in option awards, $380.6K in salary and $13.5K in other compensation.
Rankings
In 2023, Kristin Yarema's compensation ranked 411th out of 2,978 executives tracked by ExecPay. In other words, Yarema earned more than 86.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 411 out of 2,978 | 86th |
Division Manufacturing | 233 out of 1,637 | 86th |
Major group Chemicals And Allied Products | 163 out of 906 | 82nd |
Industry group Drugs | 160 out of 869 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 57 out of 211 | 73rd |
Source: SEC filing on April 25, 2024.
Yarema's colleagues
We found two more compensation records of executives who worked with Kristin Yarema at Poseida Therapeutics in 2023.